IMAX (IMAX) Q1 2026 Earnings Transcript

IMAX reported Q1 revenue of $81.4 million, down $5 million year over year, but adjusted net income rose 33% to $10 million and the company reaffirmed 2026 guidance for $1.4 billion in global box office, 160-175 installations, and at least a 45% adjusted EBITDA margin. Outside Greater China, box office grew 67%, led by 75% growth in North America and 60% growth in the rest of world, while April box office topped $105 million, up more than 15% year over year. Management also highlighted a record HOYTS deal, over 40 year-to-date system signings across 10 countries, and a strong content pipeline including The Odyssey and Dune: Part 3.

Analysis

The key setup is not the headline revenue miss; it is the combination of accelerating global slate density and selective capital intensity ahead of a likely step-up in per-screen productivity. IMAX is effectively pulling forward network monetization by subsidizing faster installs in markets where penetration is still low, which should expand not just unit count but the addressable pool for premium-priced tentpoles and local-language titles over the next 4-8 quarters.

The market may be underappreciating how much of the 2026 story is a geographic mix shift rather than a simple box-office rebound. China remains the swing factor, but management’s emphasis on spreading the slate across Hollywood, local language, and alternative content reduces single-market dependence and makes earnings less brittle than prior cycles; that matters because the stock has historically traded as if China alone determined the quarter. The bigger second-order effect is on exhibitors: HOYTS, Japan, EMEA partners, and select circuits are being incentivized to expand faster, which can pressure near-term cash flow but should lengthen IMAX’s installed base runway and increase bargaining power with studios.

The contrarian risk is that consensus may be overestimating operating leverage from box office growth. Marketing is being pulled forward, lease incentives are rising, and the mix includes more JV/hybrid economics where cash conversion lags reported box office momentum; in other words, top-line upside may not translate cleanly into margin expansion in the next 1-2 quarters. The real catalyst is not Q1 itself but whether June-July tentpoles and 70mm sellouts sustain the current quarter-to-date pace; if they do, the 45% EBITDA floor may prove conservative, but if the slate underperforms, the stock can de-rate quickly because so much of the valuation is tied to 2H execution.

Key Decisions for Investors

• Long IMAX into the next 6-10 weeks ahead of The Odyssey / Dune III marketing ramp; best risk/reward is a momentum continuation trade if Q2 box office stays >10% YoY, with downside protected by the already de-risked balance sheet and low leverage.
• Use call spreads rather than outright shares for IMAX (3-6 month horizon): buy near-dated upside on any post-earnings consolidation, since the stock’s fundamental catalyst path is event-driven but cash conversion can be noisy quarter-to-quarter.
• Pair long IMAX vs short DIS for the next 1-2 quarters if you want exposure to premium-format content monetization without studio-branded execution risk; IMAX has cleaner operating leverage to tentpole success and less legacy-asset drag.
• Trim or hedge if box office momentum in June slips below 10% YoY for two consecutive weeks; that would signal the current slate is not broad enough to offset China volatility and the market will start discounting the 2026 EBITDA floor.
• Watch for a tactical long on exhibitor partners with high IMAX concentration in Australia/Japan only on confirmation of install acceleration; those names get the second-order benefit if IMAX’s incentives translate into faster location openings, but the setup is higher beta and should be sized smaller.